Prawo i regulacje · 29/07/2005

DEA Proposes Placement of Embutramide into Schedule III of Controlled Substances Act

The Drug Enforcement Administration (DEA) has proposed placing the substance embutramide, including its salts, into Schedule III of the Controlled Substances Act (CSA), following a recommendation from the Acting Assistant Secretary for Health of the Department of Health and Human Services (DHHS) and an evaluation of relevant data by the DEA.